NCT00120874 - Memantine and Comprehensive, Individualized Management of Alzheimer's Disease and Caregiver Training | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2011

Conditions

Alzheimer's Disease

Interventions

BEHAVIORAL

Individualized management of AD including caregiver training

Individualized management program: consists of home visits to get the patient exercising, doing enjoyable activities and cognitive stimulation, educational sessions for caregivers on coping with difficult situations and a caregiver support group to help with questions and emotional concerns.

DRUG

Memantine

Patients receive 10 milligrams of memantine twice daily.

Trial Locations (1)

10016

Fisher Alzheimer's Program, New York University School of Medicine, New York